6Mizoshita T,Kataoka H,Kubota E,et al.Gastricphenotype signetring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential meth-otrexate and 5-fluorouracil[J].Int J Clin Oncol,2008,13(4):373. 被引量：1
7Alberts SR,Cervantes A,van de Velde CJ,et al.Gastric cancer:epide-miology,pathology and treatment[J].Ann Oncol,2003,14(suppl 2):S31. 被引量：1
9Koizumi W,Kurhara M,Nakano S,et al.PhaseⅡstudy of S-1,a novel oralderivative of 5-fluorouracil,in advanced gastic cancer[J].Oncology,2000,58:191. 被引量：1
10Chollet P,Schoffski P,Weigang-Kohler K,et al.PhaseⅡtrialwith S-1 in chemotherapy-naive patientswith gastric cancer.A trial performed by the EORTC Early Clinical Studies Group(ECSG)[J].Eur J Cancer,2003,39:1264. 被引量：1
3Toda Y,Machida N,Boku N. The role of oral furopyrimidinesin colorectal cancer treatment-a review[J].Gan To KagakuRyoho,2010,37(7) : 1198-1202. 被引量：1
4Hong YS,Park YS,Lim HY’et al. S-l plus oxaliplatin versuscapecitabine plus oxaliplatin for first-line treatment of pa-tients with metastatic colorectal cancer : a randomized, nonin-feriority phase 3 trial[ J]. Lancet Oncol, 2012,13(11):1125-1132. 被引量：1
6Chang YS,Chang SJ,Yeh KT,et al.RAS,BRAF,and TP53 Gene Mutations in Taiwan Residents Colorectal Cancer Patients. Onkologie . 2013 被引量：1
7John H. Strickler,Herbert I. Hurwitz.??Palliative Treatment of Metastatic Colorectal Cancer: What is the Optimal Approach?(J)Current Oncology Reports . 2014 (1) 被引量：1
8Kennecke H,Chen L,Blanke CD,et al.Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer. Curr Oncol . 2013 被引量：1
9Yong Sang Hong,Young Suk Park,Ho Yeong Lim,Jeeyun Lee,Tae Won Kim,Kyu-pyo Kim,Sun Young Kim,Ji Yeon Baek,Jee Hyun Kim,Keun-Wook Lee,Ik-Joo Chung,Sang-Hee Cho,Kyung Hee Lee,Sang Joon Shin,Hye Jin Kang,Dong Bok Shin,Sook Jung Jo,Jae Won Lee.??S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial(J)Lancet Oncology . 2012 (11) 被引量：1
10Inuyama Y,Kida A,Tsukuda M,Kohno N,Satake B.(Late phase II study of S-1 in patients with advanced head and neck cancer)Gan to kagaku ryoho. Cancer & chemotherapy . 2001 被引量：1
